KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹84 Cr | ₹64 Cr | ₹69 Cr | ₹69 Cr | ₹73 Cr |
What is the latest Total Current Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹84 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹73 Cr |
How is Total Current Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹84 Cr | 31.29 | |
| Mar2024 | ₹64 Cr | -6.76 | |
| Mar2023 | ₹69 Cr | -0.59 | |
| Mar2022 | ₹69 Cr | -5.51 | |
| Mar2021 | ₹73 Cr | - | |
Compare Total Current Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹576.8 Cr | -10% | -4.1% | 5.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,431.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,772.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,884.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹107,503.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,798.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -10% |
-4.1% |
5.9% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses